(Q38379103)

2 September 2017

title

Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy (English)

1 reference

2 September 2017

F F Tessa Ververs

1

1 reference

2 September 2017

Heronimus A M Voorbij

2

1 reference

2 September 2017

Petra Zwarts

3

1 reference

2 September 2017

Svetlana V Belitser

4

1 reference

2 September 2017

Toine C G Egberts

5

1 reference

2 September 2017

Gerard H A Visser

6

1 reference

2 September 2017

Alfred F A M Schobben

7

1 reference

2 September 2017

publication date

1 January 2009

1 reference

Clinical Pharmacokinetics

2 September 2017

published in

1 reference

2 September 2017

volume

48

1 reference

2 September 2017

issue

10

1 reference

2 September 2017

page(s)

677-683

1 reference

Validation of the Edinburgh postnatal depression scale (EPDS) in non-postnatal women

2 September 2017

cites work

1 reference

12 December 2020

Clinical pharmacokinetics of sertraline

1 reference

12 December 2020

Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications

1 reference

12 December 2020

Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities

1 reference

12 December 2020

Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro.

1 reference

12 December 2020

Prevalence and patterns of antidepressant drug use during pregnancy

1 reference

12 December 2020

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

1 reference

12 December 2020

Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes

1 reference

12 December 2020

The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects

1 reference

12 December 2020

Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting

1 reference

12 December 2020

The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin

1 reference

12 December 2020

Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy

1 reference

12 December 2020

Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding

1 reference

12 December 2020

Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms

1 reference

12 December 2020

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

1 reference

12 December 2020

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

1 reference

12 December 2020

A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum.

1 reference

12 December 2020

Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study

1 reference

12 December 2020

An improved method for measurement of common tricyclic antidepressant drugs and their metabolites using normal phase HPLC

1 reference

12 December 2020

Paroxetine plasma levels: lack of correlation with efficacy or adverse events

1 reference

12 December 2020

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

1 reference

12 December 2020

Induction of CYP2D6 in pregnancy

1 reference

12 December 2020

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study

1 reference

12 December 2020

Cohort study of depressed mood during pregnancy and after childbirth

1 reference

12 December 2020

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

1 reference

12 December 2020

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

1 reference

12 December 2020

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

1 reference

12 December 2020

The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers

1 reference

12 December 2020

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

1 reference

12 December 2020

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

1 reference

12 December 2020

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

1 reference

12 December 2020

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach

1 reference

12 December 2020

Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype

1 reference

12 December 2020

Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients

1 reference

12 December 2020

Use of antidepressant medications during pregnancy: a multisite study

1 reference

12 December 2020

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

12 December 2020

Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation

1 reference

12 December 2020

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.

1 reference

12 December 2020

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy

1 reference

12 December 2020

10.2165/11318050-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1045714674

0 references

1 reference